BiotechPark with Innovation- and Incubationscenter

diagram

Berlin-Buch, with its long tradition of excellent biomedical basic and clinical research as well as clinical expertise, is an ideal environment for life science companies. The campus atmosphere is conducive to scientific exchange, technology transfer and collaborative projects.

With an area of approximately 45,000 m², the BiotechPark Berlin-Buch is one of the largest biotech parks in Germany. Here entrepreneurs and companies find affordable, industry-specific laboratory and office space with state-of-the-art facilities. Start-ups can grow and thrive in the Innovation and Incubation Center, building areas on the Campus allow for future development. The managing company, Campus Berlin-Buch GmbH, supports the companies in all matters and provides comprehensive service.
Currently, 75 companies are located on campus and employ around 850 people. More than fifty of these companies are in the biotech sector, several others offer services for the life science industry. Since 1998 the number of employees of the biotech companies has more than doubled.

The business fields of the companies range from medical technology products, molecular biological diagnostics and treatments, preclinical pharmacological and pharmacogenomic tests, RNA technologies, the search for pharma-relevant target molecules, production and testing of drugs and the analysis and synthesis of biomolecules.

From 2023 the new BerlinBioCube start-up center in BiotechPark Berlin-Buch will offer an additional 8,000 square meters of laboratory and office space and attractive services for start-ups in the fields of biotechnology and medical technology as well as adjacent areas.

„Made in Buch“ stands for high quality and innovation in the life sciences. Selected products can be found here.

Otto Warburg House

News innovation

Eckert & Ziegler and GlyTherix Sign Agreement for Lutetium-177 Supply

Eckert & Ziegler (ISIN DE0005659700, SDAX) and GlyTherix Ltd (GlyTherix), an Australian targeted radiotherapy company specialising in developing antibody radiopharmaceuticals for solid tumors, today a...

more ...

Eckert & Ziegler: Spin-off of Pentixapharm AG Registered with the Commercial Register

Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) announces that the spin-off resolution approved at the Annual General Meeting on 26 June 2024 was entered in the commercial register of the Charlottenbu...

more ...

OMEICOS Completes Enrollment of PMD-OPTION Study in Primary Mitochondrial Disease

Interim data confirms OMT-28's strong safety profile in PMD patients, top-line data expected mid-2025

more ...

Events Campus

06.11.2024, 13:30
Einladung zur Vorlesung: "Rätselhafte Gehirne - Ursachen von Demenz bei Jung und Alt"

in der Reihe "Neue Wege in der Biomedizin: Aktuelle Forschungsthemen vom Campus Berlin-Buch"

more ...

11.11.2024, 09:00
Fachkraft für Molekularbiologie

Das 11-tägige Intensiv-Seminar vermittelt Grundlagenwissen zu den wichtigsten Labormethoden der modernen Molekularbiologie und vermittelt Einblicke in die klinische Forschung.

more ...

03.12.2024, 08:00
GRUNDKURS FÜR PROJEKTLEITER UND BEAUFTRAGTE FÜR BIOLOGISCHE SICHERHEIT NACH § 28 GenTSV

In Deutschland dürfen bei gentechnischen Arbeiten in gentechnischen Anlagen nur Personen mit der erforderlichen Sachkunde zum Projektleiter und / oder zu Beauftragten für die Biologische Sicherheit be...

more ...

Sponsoren der Website: